Form 10-K BICYCLE THERAPEUTICS For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Bicycle Therapeutics (BCYC) PT Lowered to $42 at Jefferies
February 25, 2025 2:12 PM ESTJefferies analyst Biren Amin lowered the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $42.00 (from $53.00) while maintaining a Buy rating.
The analyst comments "For the FY24 updates, BCYC highlighted Zele+pembo Ph1 data in 1L UC (65%/25% ORR/CR), and Ph2/3 Duravelo-2... More
Rodman & Renshaw Reiterates Buy Rating on Bicycle Therapeutics (BCYC)
February 25, 2025 9:45 AM ESTRodman & Renshaw analyst Tony Butler reiterated a Buy rating and $33.00 price target on Bicycle Therapeutics (NASDAQ: BCYC)
The analyst comments "Bicycle Therapeutics plc (BCYC; Buy) provided its 4Q24 and FY2024 business updates this morning before the markets opened. Recall that Bicycles clinical pipeline consists of Bicycle-Toxin Conjugates (BTC) and Bicycle-radio conjugates (BRC) against solid tumors.... More
